DRI Healthcare Trust (TSX:DHT.UN)
16.07
+0.20 (1.26%)
At close: Jan 9, 2026
DRI Healthcare Trust Company Description
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties.
It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas.
The company was incorporated in 2020 and is headquartered in Toronto, Canada.
DRI Healthcare Trust
| Country | Canada |
| Founded | 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Behzad Khosrowshahi |
Contact Details
Address: 100 King Street West Toronto, ON M5X 1B1 Canada | |
| Phone | 416 863 1865 |
| Website | dricapital.com |
Stock Details
| Ticker Symbol | DHT.UN |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA23344H1091 |
| SIC Code | 6722 |
Key Executives
| Name | Position |
|---|---|
| Zaheed Mawani CPA | Chief Financial Officer |
| Navin Cyriac Jacob | Executive Vice President, Head of Investments and Research - DRI Capital Inc. |
| Babak Farahmand | Executive Vice President of Asset Operations and Analytics - DRI Capital Inc. |
| Emmanuel Coeytaux | Executive Vice President of Strategy |
| Lee Schechter | Senior Vice President of Research and Investments |